NovAccess Global Announces Uplisting to OTCQB
NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
NovAccess Global CEO Dwain Irvin Featured on MoneyTV
NovAccess Global to Participate in LD Micro Invitational XII Conference
NovAccess Global Closes its Redemption Transaction and expands the Executive Board
NovAccess Global, Inc.’s CEO to attend BIO Conference in New York
NovAccess Global, Inc. Names Neil Laird, Chief Financial Officer
NovAccess Global, Inc. Expands Advisory Board
NovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World Congress
NovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDA
